iBio Inc (NASDAQ:IBIO) has a beta value of 0.61 and has seen 0.44 million shares traded in the recent trading session. The company, currently valued at $12.23M, closed the recent trade at $0.75 per share which meant it lost -$0.01 on the day or -1.42% during that session. The IBIO stock price is -818.67% off its 52-week high price of $6.89 and 14.67% above the 52-week low of $0.64. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.82 million shares traded. The 3-month trading volume is 2.69 million shares.
The consensus among analysts is that iBio Inc (IBIO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
iBio Inc (NASDAQ:IBIO) trade information
Sporting -1.42% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the IBIO stock price touched $0.75 or saw a rise of 12.78%. Year-to-date, iBio Inc shares have moved -65.09%, while the 5-day performance has seen it change -9.76%. Over the past 30 days, the shares of iBio Inc (NASDAQ:IBIO) have changed -26.79%. Short interest in the company has seen 0.83 million shares shorted with days to cover at 1.75.
Wall Street analysts have a consensus price target for the stock at $3.6, which means that the shares’ value could jump 79.17% from the levels at last check today.. The projected low price target is $3.6 while the price target rests at a high of $3.6. In that case, then, we find that the latest price level in today’s session is -380.0% off the targeted high while a plunge would see the stock gain -380.0% from the levels at last check today..
iBio Inc (IBIO) estimates and forecasts
The company’s shares have lost -70.43% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.55% over the past 5 years.
IBIO Dividends
iBio Inc is expected to release its next earnings report on 2025-May-02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders own 4.31% of the company shares, while shares held by institutions stand at 15.78% with a share float percentage of 16.49%. Investors are also buoyed by the number of investors in a company, with iBio Inc having a total of 38.0 institutions that hold shares in the company. The top two institutional holders are LYNX1 CAPITAL MANAGEMENT LP with over 0.6 million shares worth more than $1.27 billion. As of 2024-06-30, LYNX1 CAPITAL MANAGEMENT LP held 6.9576% of shares outstanding.
The other major institutional holder is IKARIAN CAPITAL, LLC, with the holding of over 0.6 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.27 million and represent 6.9576% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.85% shares in the company for having 138.4 shares of worth $0.1 million while later fund manager owns 54.08 shares of worth $40972.0 as of May 31, 2025 , which makes it owner of about 0.33% of company’s outstanding stock.
